Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Sales | 8,249 | 40,560 | 0 | 0 | 0 |
| Cost of Goods | N/A | 2,500 | N/A | N/A | N/A |
| Gross Profit | 8,249 | 38,060 | N/A | N/A | N/A |
| Operating Expenses | 482,731 | 304,800 | 183,660 | 43,858 | 0 |
| Operating Income | -474,482 | -266,240 | -183,660 | -43,858 | N/A |
| Interest Expense | 36,655 | 8,765 | 2,547 | 13 | 0 |
| Other Income | 5,649 | -13,580 | 16,756 | 39 | 0 |
| Pre-tax Income | -505,488 | -288,585 | -169,451 | -43,832 | 0 |
| Net Income Continuous | -505,488 | -288,585 | -169,451 | -43,832 | N/A |
| Minority Interests | -56,764 | -27,998 | -38,702 | -13,267 | N/A |
| Net Income | $-448,724 | $-260,587 | $-130,749 | $-30,565 | $N/A |
| EPS Basic Total Ops | -3.80 | -2.48 | -2.12 | -1.00 | N/A |
| EPS Basic Continuous Ops | -4.28 | -2.75 | -2.74 | -1.43 | N/A |
| EPS Diluted Total Ops | -3.80 | -2.48 | -2.12 | -1.00 | N/A |
| EPS Diluted Continuous Ops | -4.28 | -2.75 | -2.74 | -1.43 | N/A |
| EPS Diluted Before Non-Recurring Items | -3.80 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-473,026 | $-265,381 | $-183,660 | $-43,858 | $N/A |